简体中文 | 繁體中文 | English

Press Releases

2018-09-14 18:06 City of Aurora, CO Replaces Tape Backups with Disk-based ExaGrid System
2018-09-14 16:21 USA and Canada to Lead Global Migration to 5G Finds GSMA Study
2018-09-14 15:48 IBC and TM Forum Announce Launch of Five New Catalyst Projects for 2019
2018-09-14 15:45 International Icon and Humanitarian Pelé Announces the Launch of His New Global Charitable Foundation
2018-09-14 15:41 Kiwisat Subscribers to Enjoy Augmented Channel Bouquet via SES
2018-09-14 13:58 New GSMA Report Highlights How 5G, Artificial Intelligence and IoT Will Transform the Americas
2018-09-14 13:52 Acelity Enters Agreement to Transition Systagenix Manufacturing Facility to Scapa Healthcare
2018-09-14 13:50 WE Communications’ Brands in Motion 2018 Global Study: Escalating Consumer Expectations Push Brands to Deliver on Innovation, Ethical Responsibility and Functionality
2018-09-14 12:16 WCG 2019 Finals to Be Held in Xi'an China in July 2019
2018-09-14 10:51 Andersen Global Continues Expansion in Middle East with Zalloum & Laswi Law Firm
2018-09-14 10:10 Acceleration Partners Expands Global Performance-Driven Partner Marketing to Asia-Pacific
2018-09-14 10:07 ABB and Nobel Media Announce International Partnership
2018-09-14 10:04 Alvarez & Marsal Expands Its Footprint to the Cayman Islands Bolstering Its Insolvency and Restructuring Offerings
2018-09-14 09:34 Busan Metropolitan City to Host the 23rd Busan International Film Festival and G-STAR 2018
2018-09-13 18:08 North American Tier-1 Operator Launches New Services on Mavenir’s NFV CloudRange™ Platform
2018-09-13 18:06 Luxembourg Launches Business-Focused National Space Agency
2018-09-13 16:57 HDF Energy Announces Meridiam's Investment in CEOG, Currently the Greatest Project Worldwide of a Power Generating Plant Storing Intermittent Renewable Energy Using Hydrogen
2018-09-13 16:13 BIOCAD and SPH Agree to Build a Drug Substance Manufacturing Facility in China
2018-09-13 16:09 OptraSCAN® Receives CE Mark Approval for In-Vitro Diagnostics Use
2018-09-13 14:38 Boehringer Ingelheim Acquires All ViraTherapeutics Shares to Develop Next Generation Viral-Based Immuno-Oncology Therapies